Heart failure (HF), often referred to as congestive heart failure (CHF), is when the heart is unable to pump sufficiently to maintain blood flow to meet the body''s needs.
In 2019, the market size of Congestive Heart Failure (CHF) is 17900 million US$ and it will reach 27500 million US$ in 2025, growing at a CAGR of 5.5% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Congestive Heart Failure (CHF).
This report studies the global market size of Congestive Heart Failure (CHF), especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Congestive Heart Failure (CHF) sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Abiomed
Berlin Heart
Biotronik
Boston Scientific
HeartWare
Jarvik Heart
LivaNova
Medtronic
ReliantHeart
St. Jude Medical
Market Segment by Product Type
ICDs
VADs
Others
Market Segment by Application
Hospital
Clinic
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Congestive Heart Failure (CHF) status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Congestive Heart Failure (CHF) manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Congestive Heart Failure (CHF) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
In 2019, the market size of Congestive Heart Failure (CHF) is 17900 million US$ and it will reach 27500 million US$ in 2025, growing at a CAGR of 5.5% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Congestive Heart Failure (CHF).
This report studies the global market size of Congestive Heart Failure (CHF), especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Congestive Heart Failure (CHF) sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Abiomed
Berlin Heart
Biotronik
Boston Scientific
HeartWare
Jarvik Heart
LivaNova
Medtronic
ReliantHeart
St. Jude Medical
Market Segment by Product Type
ICDs
VADs
Others
Market Segment by Application
Hospital
Clinic
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Congestive Heart Failure (CHF) status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Congestive Heart Failure (CHF) manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Congestive Heart Failure (CHF) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Congestive Heart Failure (CHF) Market Size Growth Rate by Type (2019-2025)
1.3.2 ICDs
1.3.3 VADs
1.3.4 Others
1.4 Market Segment by Application
1.4.1 Global Congestive Heart Failure (CHF) Market Share by Application (2019-2025)
1.4.2 Hospital
1.4.3 Clinic
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Congestive Heart Failure (CHF) Market Size
2.1.1 Global Congestive Heart Failure (CHF) Revenue 2014-2025
2.1.2 Global Congestive Heart Failure (CHF) Sales 2014-2025
2.2 Congestive Heart Failure (CHF) Growth Rate by Regions
2.2.1 Global Congestive Heart Failure (CHF) Sales by Regions 2014-2019
2.2.2 Global Congestive Heart Failure (CHF) Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Congestive Heart Failure (CHF) Sales by Manufacturers
3.1.1 Congestive Heart Failure (CHF) Sales by Manufacturers 2014-2019
3.1.2 Congestive Heart Failure (CHF) Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Congestive Heart Failure (CHF) Revenue by Manufacturers (2014-2019)
3.2.2 Congestive Heart Failure (CHF) Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Congestive Heart Failure (CHF) Market Concentration Ratio (CR5 and HHI)
3.3 Congestive Heart Failure (CHF) Price by Manufacturers
3.4 Key Manufacturers Congestive Heart Failure (CHF) Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Congestive Heart Failure (CHF) Market
3.6 Key Manufacturers Congestive Heart Failure (CHF) Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 ICDs Sales and Revenue (2014-2019)
4.1.2 VADs Sales and Revenue (2014-2019)
4.1.3 Others Sales and Revenue (2014-2019)
4.2 Global Congestive Heart Failure (CHF) Sales Market Share by Type
4.3 Global Congestive Heart Failure (CHF) Revenue Market Share by Type
4.4 Congestive Heart Failure (CHF) Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Congestive Heart Failure (CHF) Sales by Application
6 United States
6.1 United States Congestive Heart Failure (CHF) Breakdown Data by Company
6.2 United States Congestive Heart Failure (CHF) Breakdown Data by Type
6.3 United States Congestive Heart Failure (CHF) Breakdown Data by Application
7 European Union
7.1 European Union Congestive Heart Failure (CHF) Breakdown Data by Company
7.2 European Union Congestive Heart Failure (CHF) Breakdown Data by Type
7.3 European Union Congestive Heart Failure (CHF) Breakdown Data by Application
8 China
8.1 China Congestive Heart Failure (CHF) Breakdown Data by Company
8.2 China Congestive Heart Failure (CHF) Breakdown Data by Type
8.3 China Congestive Heart Failure (CHF) Breakdown Data by Application
9 Rest of World
9.1 Rest of World Congestive Heart Failure (CHF) Breakdown Data by Company
9.2 Rest of World Congestive Heart Failure (CHF) Breakdown Data by Type
9.3 Rest of World Congestive Heart Failure (CHF) Breakdown Data by Application
9.4 Rest of World Congestive Heart Failure (CHF) Breakdown Data by Countries
9.4.1 Rest of World Congestive Heart Failure (CHF) Sales by Countries
9.4.2 Rest of World Congestive Heart Failure (CHF) Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Abiomed
10.1.1 Abiomed Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Congestive Heart Failure (CHF)
10.1.4 Congestive Heart Failure (CHF) Product Introduction
10.1.5 Abiomed Recent Development
10.2 Berlin Heart
10.2.1 Berlin Heart Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Congestive Heart Failure (CHF)
10.2.4 Congestive Heart Failure (CHF) Product Introduction
10.2.5 Berlin Heart Recent Development
10.3 Biotronik
10.3.1 Biotronik Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Congestive Heart Failure (CHF)
10.3.4 Congestive Heart Failure (CHF) Product Introduction
10.3.5 Biotronik Recent Development
10.4 Boston Scientific
10.4.1 Boston Scientific Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Congestive Heart Failure (CHF)
10.4.4 Congestive Heart Failure (CHF) Product Introduction
10.4.5 Boston Scientific Recent Development
10.5 HeartWare
10.5.1 HeartWare Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Congestive Heart Failure (CHF)
10.5.4 Congestive Heart Failure (CHF) Product Introduction
10.5.5 HeartWare Recent Development
10.6 Jarvik Heart
10.6.1 Jarvik Heart Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Congestive Heart Failure (CHF)
10.6.4 Congestive Heart Failure (CHF) Product Introduction
10.6.5 Jarvik Heart Recent Development
10.7 LivaNova
10.7.1 LivaNova Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Congestive Heart Failure (CHF)
10.7.4 Congestive Heart Failure (CHF) Product Introduction
10.7.5 LivaNova Recent Development
10.8 Medtronic
10.8.1 Medtronic Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Congestive Heart Failure (CHF)
10.8.4 Congestive Heart Failure (CHF) Product Introduction
10.8.5 Medtronic Recent Development
10.9 ReliantHeart
10.9.1 ReliantHeart Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Congestive Heart Failure (CHF)
10.9.4 Congestive Heart Failure (CHF) Product Introduction
10.9.5 ReliantHeart Recent Development
10.10 St. Jude Medical
10.10.1 St. Jude Medical Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Congestive Heart Failure (CHF)
10.10.4 Congestive Heart Failure (CHF) Product Introduction
10.10.5 St. Jude Medical Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Congestive Heart Failure (CHF) Sales Channels
11.2.2 Congestive Heart Failure (CHF) Distributors
11.3 Congestive Heart Failure (CHF) Customers
12 Market Forecast
12.1 Global Congestive Heart Failure (CHF) Sales and Revenue Forecast 2019-2025
12.2 Global Congestive Heart Failure (CHF) Sales Forecast by Type
12.3 Global Congestive Heart Failure (CHF) Sales Forecast by Application
12.4 Congestive Heart Failure (CHF) Forecast by Regions
12.4.1 Global Congestive Heart Failure (CHF) Sales Forecast by Regions 2019-2025
12.4.2 Global Congestive Heart Failure (CHF) Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Congestive Heart Failure (CHF) Market Size Growth Rate by Type (2019-2025)
1.3.2 ICDs
1.3.3 VADs
1.3.4 Others
1.4 Market Segment by Application
1.4.1 Global Congestive Heart Failure (CHF) Market Share by Application (2019-2025)
1.4.2 Hospital
1.4.3 Clinic
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Congestive Heart Failure (CHF) Market Size
2.1.1 Global Congestive Heart Failure (CHF) Revenue 2014-2025
2.1.2 Global Congestive Heart Failure (CHF) Sales 2014-2025
2.2 Congestive Heart Failure (CHF) Growth Rate by Regions
2.2.1 Global Congestive Heart Failure (CHF) Sales by Regions 2014-2019
2.2.2 Global Congestive Heart Failure (CHF) Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Congestive Heart Failure (CHF) Sales by Manufacturers
3.1.1 Congestive Heart Failure (CHF) Sales by Manufacturers 2014-2019
3.1.2 Congestive Heart Failure (CHF) Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Congestive Heart Failure (CHF) Revenue by Manufacturers (2014-2019)
3.2.2 Congestive Heart Failure (CHF) Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Congestive Heart Failure (CHF) Market Concentration Ratio (CR5 and HHI)
3.3 Congestive Heart Failure (CHF) Price by Manufacturers
3.4 Key Manufacturers Congestive Heart Failure (CHF) Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Congestive Heart Failure (CHF) Market
3.6 Key Manufacturers Congestive Heart Failure (CHF) Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 ICDs Sales and Revenue (2014-2019)
4.1.2 VADs Sales and Revenue (2014-2019)
4.1.3 Others Sales and Revenue (2014-2019)
4.2 Global Congestive Heart Failure (CHF) Sales Market Share by Type
4.3 Global Congestive Heart Failure (CHF) Revenue Market Share by Type
4.4 Congestive Heart Failure (CHF) Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Congestive Heart Failure (CHF) Sales by Application
6 United States
6.1 United States Congestive Heart Failure (CHF) Breakdown Data by Company
6.2 United States Congestive Heart Failure (CHF) Breakdown Data by Type
6.3 United States Congestive Heart Failure (CHF) Breakdown Data by Application
7 European Union
7.1 European Union Congestive Heart Failure (CHF) Breakdown Data by Company
7.2 European Union Congestive Heart Failure (CHF) Breakdown Data by Type
7.3 European Union Congestive Heart Failure (CHF) Breakdown Data by Application
8 China
8.1 China Congestive Heart Failure (CHF) Breakdown Data by Company
8.2 China Congestive Heart Failure (CHF) Breakdown Data by Type
8.3 China Congestive Heart Failure (CHF) Breakdown Data by Application
9 Rest of World
9.1 Rest of World Congestive Heart Failure (CHF) Breakdown Data by Company
9.2 Rest of World Congestive Heart Failure (CHF) Breakdown Data by Type
9.3 Rest of World Congestive Heart Failure (CHF) Breakdown Data by Application
9.4 Rest of World Congestive Heart Failure (CHF) Breakdown Data by Countries
9.4.1 Rest of World Congestive Heart Failure (CHF) Sales by Countries
9.4.2 Rest of World Congestive Heart Failure (CHF) Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Abiomed
10.1.1 Abiomed Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Congestive Heart Failure (CHF)
10.1.4 Congestive Heart Failure (CHF) Product Introduction
10.1.5 Abiomed Recent Development
10.2 Berlin Heart
10.2.1 Berlin Heart Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Congestive Heart Failure (CHF)
10.2.4 Congestive Heart Failure (CHF) Product Introduction
10.2.5 Berlin Heart Recent Development
10.3 Biotronik
10.3.1 Biotronik Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Congestive Heart Failure (CHF)
10.3.4 Congestive Heart Failure (CHF) Product Introduction
10.3.5 Biotronik Recent Development
10.4 Boston Scientific
10.4.1 Boston Scientific Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Congestive Heart Failure (CHF)
10.4.4 Congestive Heart Failure (CHF) Product Introduction
10.4.5 Boston Scientific Recent Development
10.5 HeartWare
10.5.1 HeartWare Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Congestive Heart Failure (CHF)
10.5.4 Congestive Heart Failure (CHF) Product Introduction
10.5.5 HeartWare Recent Development
10.6 Jarvik Heart
10.6.1 Jarvik Heart Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Congestive Heart Failure (CHF)
10.6.4 Congestive Heart Failure (CHF) Product Introduction
10.6.5 Jarvik Heart Recent Development
10.7 LivaNova
10.7.1 LivaNova Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Congestive Heart Failure (CHF)
10.7.4 Congestive Heart Failure (CHF) Product Introduction
10.7.5 LivaNova Recent Development
10.8 Medtronic
10.8.1 Medtronic Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Congestive Heart Failure (CHF)
10.8.4 Congestive Heart Failure (CHF) Product Introduction
10.8.5 Medtronic Recent Development
10.9 ReliantHeart
10.9.1 ReliantHeart Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Congestive Heart Failure (CHF)
10.9.4 Congestive Heart Failure (CHF) Product Introduction
10.9.5 ReliantHeart Recent Development
10.10 St. Jude Medical
10.10.1 St. Jude Medical Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Congestive Heart Failure (CHF)
10.10.4 Congestive Heart Failure (CHF) Product Introduction
10.10.5 St. Jude Medical Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Congestive Heart Failure (CHF) Sales Channels
11.2.2 Congestive Heart Failure (CHF) Distributors
11.3 Congestive Heart Failure (CHF) Customers
12 Market Forecast
12.1 Global Congestive Heart Failure (CHF) Sales and Revenue Forecast 2019-2025
12.2 Global Congestive Heart Failure (CHF) Sales Forecast by Type
12.3 Global Congestive Heart Failure (CHF) Sales Forecast by Application
12.4 Congestive Heart Failure (CHF) Forecast by Regions
12.4.1 Global Congestive Heart Failure (CHF) Sales Forecast by Regions 2019-2025
12.4.2 Global Congestive Heart Failure (CHF) Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
